RecruitingNot Applicable

Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE

China100 participantsStarted 2023-08-31

Plain-language summary

This study aimed at comparing the performance of self-expandable valves versus balloon-expandable valves in patients with ascending aortic dilation undergoing transcatheter aortic valve replacement.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Severe aortic stenosis; * Transfemoral access; * Preoperative aortic CT suggesting maximum ascending aortic diameter ≥45mm and \<55mm; * Anticipated life expectancy \>1 year; * Age ≥ 65 years. Exclusion Criteria: * Dominant aortic regurgitation,; * A history of SAVR or TAVR; * A history of aortic surgery; * Emergent TAVR.

What they're measuring

30-day all-cause mortality

Timeframe: 30 days after TAVR procedure

30-day adverse aortic events

Timeframe: 30 days after TAVR procedure

The rate of device success

Timeframe: 30 days

Trial details

NCT IDNCT06009588

SponsorChina National Center for Cardiovascular Diseases

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2026-08-30

Contact for this trial

Kang An, MD

0085-15801301740 ankang913@126.com

View on ClinicalTrials.gov More Aortic Stenosis trials